-+ 0.00%
-+ 0.00%
-+ 0.00%

GERON CORP - TO DISCONTINUE PHASE 3 IMPACTMF TRIAL OF IMETELSTAT IN MYELOFIBROSIS - SEC FILING

Reuters·10/28/2026 20:48:24

Please log in to view news